Zeltia Eye Drug Cleared For First Trials In Spain

Reuters

Zeltia (ZEL.MC) affiliate Sylentis has been cleared by Spanish health authorities to begin phase 1 clinical trials of a drug for the treatment of ocular hyper-tension associated with glaucoma.
  • <<
  • >>

Comments